Navigation Links
CompuCyte Corporation and Program in Cellular and Molecular Medicine at Children's Hospital Boston Announce Joint Program for Quantitative Imaging Cytometry Research Services
Date:3/10/2009

BOSTON, March 10 /PRNewswire/ -- CompuCyte Corporation and the Program in Cellular and Molecular Medicine at Children's Hospital Boston (also known as the Immune Disease Institute) today announced the establishment of a joint Quantitative Imaging Cytometry program. The Program in Cellular and Molecular Medicine is an affiliate of Harvard Medical School (HMS) and is located in the Longwood Medical Area. Under the terms of the agreement, CompuCyte will make its proprietary laser scanning cytometry instrumentation and technical support programs available to trained personnel, and will provide quantitative imaging cytometry and analysis services to the larger Longwood Medical Area community.

"The joint program with CompuCyte gives our facility a new and powerful asset to offer the HMS research community. CompuCyte's instrumentation provides the ability to combine the quantitative data traditionally generated through flow cytometry with laser-scanned images of cells and tissues, without the traditional flow requirement for harsh sample-processing and the unwanted disturbance of native cells and tissue architecture normally associated with traditional cytometry," explained Dr. Natasha Barteneva, Director of the Flow and Imaging Cytometry Resource of the Program in Cellular and Molecular Medicine and manager of the joint program. "The agreement with CompuCyte expands our capacity in quantitative imaging cytometry and reinforces our commitment to providing our researchers access to the most advanced analytical technologies," stated Dr. Margaret Bradley, Chief Scientific Administrative Officer.

"Laser Scanning Cytometry (LSC) technology has become a gold standard in quantitative automated analysis of intact adherent cells, tissue specimens, tissue microarrays and small cellular samples, such as small needle aspirates," explained Dr. Elena Holden, CompuCyte's President and Chief Executive Officer. "The reputation of the Program in Cellular and Molecular Medicine for quality and scientific vigor is well known. We are enthusiastic about the opportunity to collaborate with their Flow and Imaging Cytometry Resource and to add our proprietary LSC technology to their existing infrastructure."

The Program in Cellular and Molecular Medicine at Children's Hospital Boston (also known as the Immune Disease Institute) is a non-profit research institution academically affiliated with Harvard Medical School, recognized worldwide for its discoveries that increase the body's ability to fight disease. Its mission is fundamental biomedical research to improve human health, harness inflammation, and strengthen immune defense.

CompuCyte Corporation, a private company headquartered in Westwood, Massachusetts, is a pioneer and leader in the development of quantitative imaging cytometry instrumentation based on patented laser scanning cytometry technology. The company's iCyte(R), iCys(R), and iColor(R) cytometers enable true quantitative cytometric image analysis of cellular and tissue specimens in life science research, drug safety, toxicology studies, biomarker discovery and clinical trials.


'/>"/>
SOURCE CompuCyte Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. The ScottCare Corporation Completes Acquisition of Rozinn Electronics, a Leading Manufacturer of Cardiac Diagnostic Products
2. Brooke Franchise Corporation Announces Selected July Results
3. MedThink Communications Retained by NanoBio Corporation
4. EaglePicher Corporation Completes Transaction to Sell EaglePicher Boron, LLC to Ceradyne, Inc. for $69 Million
5. Dana Corporation, Inc. Enters Into Settlement Agreement With Dana Retiree Committee
6. Memry Corporation Announces Fiscal Fourth Quarter and 2007 Year End Earnings Release and Conference Call
7. Somanetics Corporation to Release Third Quarter 2007 Financial Results and Host Conference Call September 19
8. LifeQuest World Corporation Proud Contributor to Dietary Supplement Education Alliance (DSEA)
9. DTI Medical Corporation Announces Reverse Split and Other Corporate Developments
10. STERIS Corporation Board of Directors Names Walter M. Rosebrough Jr. President and Chief Executive Officer
11. AGA Medical Corporation Receives Approval for the AMPLATZER Muscular Ventricular Septal Defect Occluder
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... Springs, California (PRWEB) , ... April 29, 2016 ... ... lies at the heart of our nation’s productivity, stability, even security. Most importantly, ... for their organizations. , Then why are American workers so unhappy? , Just ...
(Date:4/29/2016)... ... ... Conditions were ideal for Global Lyme Alliance’s (GLA) 2nd annual “Bite Back Against ... breeze and temperatures in the 60s. Over 400 runners, walkers and volunteers participated in ... 1-mile walk were held to increase awareness about Lyme disease and to raise funds ...
(Date:4/29/2016)... , ... April 29, 2016 , ... Spine Team Texas, ... is proud to announce one of their physicians has been invited to be a ... (Texas ACOFP) Family Practice Review conference on April 30, 2016. , Dr. R. ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... announces the Gyrociser, an exercise invention which aids in proper muscle development. , ... Cooper, CEO and Creative Director of World Patent Marketing. "Globalization has threatened the ...
(Date:4/29/2016)... ... April 29, 2016 , ... Dr. Robert Mondavi, one ... to improve smiles. Cosmetic dentistry is a fast-growing field as more patients are discovering ... patients to learn more about the options currently available to them and which ones ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... NEW YORK , April 28, 2016 /PRNewswire/ ... will notably complement the company,s valve repair and ... the move also places Abbott more firmly into ... one of the fastest growing device areas, with ... to its recent report,  Advanced Remote Patient ...
(Date:4/28/2016)...  Marking its one year anniversary since launching ... risk test, Color Genomics announced a ... impact the most common hereditary cancers affecting both ... analyzes hereditary cancer risks for breast, colorectal, melanoma, ... Color Test is physician ordered and includes genetic ...
(Date:4/28/2016)... -- The blood testing market in China ... and The Freedonia Group in a recent report.  The ... healthcare research firm said that China ... and in improving testing at the provincial level.   The ... Blood Testing Market in China , which utilized ...
Breaking Medicine Technology: